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Indeed, the surnames of cases 1 and 2
are of Slavic origin, suggesting an
ancestral mutation propagated through
Slavic migration to Northern Romania
and Eastern Germany, where our
patients are living. Nevertheless, the
mutation affects a CpG dinucleotide,
which has a high mutation rate from 5-
methylated CG to TG and its comple-
mentary pair CA, suggesting that it
could also be recurrent.
Altogether, we show that KS patients
may harbor FERMT1 deep-intronic muta-
tions, which are missed in targeted and
whole-exome sequencing, and require
RNA analysis or whole-genome sequen-
cing. Our results argue against a genetic
heterogeneity of KS.
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TO THE EDITOR
Palmoplantar keratodermas (PPKs) are a
group of genetically heterogeneous gen-
odermatoses. Recently mutations in
TRPV3 were identiﬁed as a cause of the
rare form of PPK, Olmsted syndrome (OS;
OMIM 614594; Lai-Cheong et al., 2012;
Lin et al., 2012; Danso-Abeam et al.,
2013; Kariminejad et al., 2014;
Duchatelet et al., 2014b). OS was ﬁrst
reported in 1927 in an Italian American
boy with painful palmoplantar kerato-
derma, deep ﬁssures, pseudoainhum,
curved thickened nails, and perioriﬁcial
hyperkeratosis with ﬁssuring (Olmsted,
1927). About 50 clinical cases of OS
have been described, and all generally
exhibit the features described by Olmsted
as well as some additional features
(Mevorah et al., 2005).
In this study, we report the case of six
families, referred to the Pachyonychia
Congenita Project for the evaluation of
painful plantar keratoderma, but lacking
pseudoainhum or signiﬁcant perioriﬁcial
keratoderma. In each case, after no
mutations were identiﬁed in the PC-
associated keratin genes, KRT6A, KRT6B,
KRT6C, KRT16, or KRT17, and in some
cases, after other candidate genes includ-
ing GJB6, DSP, DSG1, KRT5, and KRT14
had been screened, we identiﬁed hetero-
zygous missense mutations in TRPV3,
thus greatly expanding the phenotypicAccepted article preview online 12 June 2015; published online 23 July 2015
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spectrum of OS. Samples were obtained
with written, informed patient consent
and ethical approval by a Western
Institutional Review Board that complies
with principles of the Helsinki Accord.
An 18-year-old girl of European ances-
try from Family 1 initially noted focal
callus formation on the soles at age 4.
Severe, painful plantar keratoderma now
necessitates periodic use of a wheelchair.
She has mild keratoderma on the hands,
thin nail plates with koilonychia, and ﬁne
slow-growing hair. She has no perioriﬁ-
cial keratoderma (Figure 1a, b, c,
Supplementary Figure S1 online and
Supplementary Table S1 online). A likely
diagnosis was PC, but no causative
mutations were identiﬁed in the PC-
related keratin genes nor in other candi-
date genes. Therefore, a whole-exome
sequencing approach was performed
(Supplementary Methods online), and
data were analyzed for sequence variants
in known keratoderma genes. A hetero-
zygous missense mutation, p.Gly573Cys;
c,1717G4T, was identiﬁed in TRPV3
and conﬁrmed by Sanger sequencing
(Supplementary Methods online) but
was not present in her unaffected parents
or brother. This mutation has been
reported in a sporadic case of Olmsted
syndrome (Lin et al., 2012).
TRPV3 was considered a candidate
gene for ﬁve additional families in
which no mutations were identiﬁed in
the PC-associated keratin genes or in
other candidate genes. Exons and
intron/exon boundaries of TRPV3 were
ampliﬁed by PCR for Sanger sequencing
(Supplementary Methods online).
A 7-year-old Brazilian girl in Family 2
presented with easily peeling hyperker-
atosis on her toes and feet at about
18 months of age, and these have
evolved into painful, focal hyperkerato-
sis. She has erythema and hyperkerato-
sis of the distal ﬁngers and subungual
hyperkeratosis. She has had transient
perioriﬁcial hyperkeratosis and her nail
plates are normal (Figure 1d, e, f,
Table 1, Supplementary Figure S1
online). A previously unreported hetero-
zygous missense mutation, p.Gly568-
Val; c.1703G4T, was identiﬁed
(Supplementary Figure S2 online); this
mutation was not detected in either of
her unaffected parents. Amino acid, p.
Gly568 is highly conserved across
several species. This mutation is not in
the dbSNP database or the NHLBI
Exome Variant Server (http://evs.gs.
washington.edu/EVS/).
The proband from Family 3, a 38-year-
old European female, developed calluses
on her feet at the age of 8–9 years. She
now has severe plantar pain and difﬁ-
culty in walking (Figure 1g, h, i,
Table 1,Supplementary Figure S1 online).
She has thin nail plates with koilonychia.
Her father, two paternal uncles and
grandmother were similarly affected
showing autosomal dominant inheritance
of the disorder. A previously unreported
heterozygous missense mutation, p.
Gly568Asp;c.1703G4A (Supplementary
Figure S2 online), was identiﬁed in the
proband and in one affected paternal
uncle; it was not present in an unaffected
paternal uncle nor in her mother, (her
father is deceased). This mutation is not
listed in dbSNP or the NHLBI Exome
Variant Server.
Interestingly, we found the same muta-
tion, p.Gly568Asp, in Family 4 from
South America. The ﬁrst sign of a skin
abnormality in the 25-year-old proband
was peeling skin on her feet at age 4
years. Painful, focal keratoses formed on
her feet and to a lesser extent on her
hands. She has mild periungual hyperker-
atosis on her ﬁngers and toes, ony-
choschizia and longitudinal over-
curvature of several toenails. She has
no perioriﬁcial hyperkeratosis, and her
hair is normal (Table 1). No clinical
information or DNA samples were avail-
able from her parents or from other family
members.
A 55-year-old man of European
ancestry from Family 5 presented with
painful calluses on the soles of his feet.
Focal hyperkeratoses with thin sur-
rounding rim of erythema started on
his heels as a child when he started to
walk and spread to the soles of his feet.
He has thin nail plates with koilonychia
and sparse, fragile hair. He develops
severe hyperhidrosis accompanied by
burning pain in the feet and bright
erythema on the dorsal hands and feet
in response to extremes of temperature.
He has no palmar hyperkeratosis, but has
had transient perioral and periauricular
hyperkeratosis (Figure 1j, k, l, Table 1,
Supplementary Figure S1 online). He
believes that etretinate and acitretin have
signiﬁcantly improved his quality of life.
His father was also affected. A hetero-
zygous missense mutation, p.Gly573Ser;
c.1717G4A, the most commonly
reported mutation to date in TRPV3, was
identiﬁed in this individual.
Mutation p.Gly573Ser, was also
found in a 7-year-old girl of European
ancestry (Family 6), who developed
thickening of the skin on her heels at
about 4 years of age (Table 1). She has
severe plantar pain and now uses
crutches to aid her mobility. Her parents
are unaffected.
The genetic basis of autosomal domi-
nant OS was recently elucidated
(Lin et al., 2012) when heterozygous
missense mutation, p.Gly573Ser, was
identiﬁed in TRPV3 in a Chinese family.
Mutations in TRPV3 were subsequently
identiﬁed in ﬁve additional Chinese fami-
lies. All developed symptoms before
1 year of age, had varying severity
of palmoplantar hyperkeratosis, periori-
ﬁcial hyperkeratosis, alopecia, and
severe lesional pain and itch. All but
one had constricting digital bands.
Several heterozygous mutations have
been reported at codons 573; p.
Gly573Ser (Lai-Cheong et al., 2012), p.
Gly573Ala (Danso-Abeam et al., 2013),
and p.Gly573Cys (Lin et al., 2012) and
two mutations at codons 692; p.
Trp692Gly (Lin et al., 2012) and p.
Trp692Cys (Kariminejad et al., 2014).
The heterozygous missense mutation p.
Leu673Phe was found in a patient with
OS and erythromelalgia (Duchatelet
et al., 2014b). Homozygous missense
and compound heterozygous mutations
in TRPV3 have been shown to result in
recessive OS with (Duchatelet et al.,
2014a) or without erythromelalgia (Eytan
et al., 2014). Recently, the heterozygous
missense mutation p.Gln580Pro was
identiﬁed in a family with focal
palmoplantar keratoderma (He et al.,
2015), more reminiscent of the cases
described here.
TRPV3 belongs to the family of tran-
sient receptor potential (TRP) cation
channels and is widely expressed in
keratinocytes and hair follicles (Peier
et al., 2002 Nilius et al., 2013) as well
as in other tissues including the brain,
spinal cord, sensory neurons, and the
cornea. Mutations in TRPV3 causing
autosomal dominant OS were shown to
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be gain-of-function mutations resulting in
increased TRPV3 activity (Lin et al.,
2012). In this study, two, to our knowl-
edge previously unreported, mutations
were identiﬁed at codon 568. Interes-
tingly another amino acid substitution at
this position, p.Gly568Cys, was recently
reported in combination with a splice site
mutation, exhibiting autosomal recessive
inheritance in this case (Duchatelet et al.,
2014a). TRPV3 forms a tetrameric
complex, each subunit consists of six
transmembrane domains (S1–S6) and a
cytoplasmic amino and carboxy termini
(Supplementary Figure S2 online). p.
Gly568 is within the linker region
between S4 and S5, near the boundary
of S4. It is predicted that substitution
Family 2
Family 1
Family 3
Family 5
Figure 1. Clinical features. Proband of Family 1: (a) severe calluses on the weight-bearing areas of the soles (at age 9), (b) thin nail plates with koilonychia (age
9), and (c) no perioral keratoderma and ﬁne hair, age 12. Proband of Family 2: (d) calluses on the soles of the feet, (e) blisters and peeling of skin on the ﬁngertips,
and (f) lack of perioral hyperkeratosis. Proband of Family 3: (g) calluses on the soles, (h) koilonychia of nails, and (i) no perioral lesions. Proband of Family 5: (j)
hyperkeratosis on the soles, (k) no palmar hyperkeratosis, and (l) sparse fragile hair, mild lateral perioral ﬁssuring, and no oral leukokeratosis. Images are published
with patients' consent.
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of this glycine is less damaging than
substitutions further within the S4–S5
linker such as p.Gly573 (Duchatelet
et al., 2014a). In silico prediction tools
(PolyPhen and Mutation Taster) predict
all three variants at codon 568, p.
Gly568Asp, p.Gly568Val (this study),
and p.Gly568Cys (Duchatelet et al.,
2014a) to be damaging. In our families,
no other mutations were identiﬁed in
TRPV3, and in Family 2, the parents were
wild-type for p.Gly568 indicating a de
novo mutation, p.Gly568Val, in the
proband. Mutation p.Gly568Asp was
shown to be dominantly inherited in
Family 3; the mutation was identiﬁed in
the proband and an affected paternal
uncle (affected father is deceased). How-
ever, in the family reported with p.
Gly568Cys in combination with a splice
site mutation (Duchatelet et al., 2014a)
the unaffected father was heterozygous
for p.Gly568Cys and the clinical pheno-
type of the two affected brothers was
signiﬁcantly different. Overall, these ﬁnd-
ings suggest that environmental factors/
modiﬁer genes may also be involved in
determining the phenotypic variability.
TRPV3 is involved in many cellular and
physiological processes. Recently, Cheng
et al. (2010) demonstrated the important
role of TRPV3 in regulating EGFR
signaling in hair and skin barrier
function using a TRPV3 knockout mouse
model that developed a wavy hair coat
and curly whiskers in addition to a red,
dry scaly skin at birth, reminiscent of
mice with a defective skin barrier.
Although reported as a thermosensitive
cation channel, activated at 30–33 °C,
this thermosensory role is unclear (Nilius
and Biro, 2013). Interestingly, coexis-
tence of erythromelalgia with OS has
been reported (Duchatelet et al., 2014a,
b), and one of our patients has ﬁndings
compatible with erythromelalgia. Many
OS patients report hyperhidrosis
(including four of ours).
In this study, heterozygous missense
mutations were identiﬁed in TRPV3 in six
families, (two previously unreported and
two recurrent mutations) with painful,
palmoplantar keratoderma. Clinically,
none were as severe as typical OS
(Table 1).
The cases we have described expand
the phenotypic spectrum of Olmsted
syndrome caused by mutations in
TRPV3. Mutations in TRPV3 should be
considered as a cause of painful PPK
even in the absence of perioriﬁcial
hyperkeratosis and pseudoainhum as
described by Olmsted. In contrast and
to avoid confusion, painful PPKs caused
by mutations in genes other than TRPV3
probably should not be referred to as
Olmsted syndrome.
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